Stay updated on EViSCO Clinical Trial: EBV Suppression in COPD

Sign up to get notified when there's something new on the EViSCO Clinical Trial: EBV Suppression in COPD page.
Latest website image capture
Clouds background image

Latest updates to the EViSCO Clinical Trial: EBV Suppression in COPD page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH announcement banner about agency terminology changes and related transition updates is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T08:54:39.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T10:49:41.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website changes and a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T11:16:05.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T10:38:41.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The revision label in the footer changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T09:55:13.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, rendering the study record inaccessible. This indicates a permissions issue rather than a substantive content update.
    Difference
    18%
    Check dated 2026-09-20T08:22:24.000Z thumbnail image

Stay in the know with updates to EViSCO Clinical Trial: EBV Suppression in COPD

Enter your email address, and we'll notify you when there's something new on the EViSCO Clinical Trial: EBV Suppression in COPD page.